1. Home
  2. LIXT vs TMDE Comparison

LIXT vs TMDE Comparison

Compare LIXT & TMDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • TMDE
  • Stock Information
  • Founded
  • LIXT 2005
  • TMDE 2016
  • Country
  • LIXT United States
  • TMDE Malaysia
  • Employees
  • LIXT N/A
  • TMDE N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • TMDE Oil Refining/Marketing
  • Sector
  • LIXT Health Care
  • TMDE Energy
  • Exchange
  • LIXT Nasdaq
  • TMDE Nasdaq
  • Market Cap
  • LIXT 24.4M
  • TMDE 20.4M
  • IPO Year
  • LIXT N/A
  • TMDE 2025
  • Fundamental
  • Price
  • LIXT $4.81
  • TMDE N/A
  • Analyst Decision
  • LIXT
  • TMDE
  • Analyst Count
  • LIXT 0
  • TMDE 0
  • Target Price
  • LIXT N/A
  • TMDE N/A
  • AVG Volume (30 Days)
  • LIXT 155.1K
  • TMDE 55.3K
  • Earning Date
  • LIXT 11-11-2025
  • TMDE 09-29-2025
  • Dividend Yield
  • LIXT N/A
  • TMDE N/A
  • EPS Growth
  • LIXT N/A
  • TMDE N/A
  • EPS
  • LIXT N/A
  • TMDE N/A
  • Revenue
  • LIXT N/A
  • TMDE $607,422,733.00
  • Revenue This Year
  • LIXT N/A
  • TMDE N/A
  • Revenue Next Year
  • LIXT N/A
  • TMDE N/A
  • P/E Ratio
  • LIXT N/A
  • TMDE N/A
  • Revenue Growth
  • LIXT N/A
  • TMDE N/A
  • 52 Week Low
  • LIXT $0.64
  • TMDE $0.67
  • 52 Week High
  • LIXT $6.26
  • TMDE $6.27
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 51.75
  • TMDE N/A
  • Support Level
  • LIXT $4.77
  • TMDE N/A
  • Resistance Level
  • LIXT $5.53
  • TMDE N/A
  • Average True Range (ATR)
  • LIXT 0.47
  • TMDE 0.00
  • MACD
  • LIXT -0.08
  • TMDE 0.00
  • Stochastic Oscillator
  • LIXT 21.66
  • TMDE 0.00

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

Share on Social Networks: